Select Topic:
Browse by Series:

Coming Soon: Shifting Paradigms in Ovarian Cancer

Insights From: Bradley J. Monk, MD, Creighton University School of Medicine
Published: Thursday, Mar 28, 2019



Transcript: 

Bradley J. Monk, MD, FACOG, FACS: There has been great progress in improving outcomes for patients with ovarian cancer, but this remains an area of great challenge and heterogeneity. Much work remains before we can offer all patients a significant chance at cure. Emerging approaches to personalized treatment are continually moving us toward that goal, and the hope is that with a greater understanding of underlying biology and personalized care, we can continue to develop agents that are both efficacious and tolerable.

Greetings, my name is Bradley Monk. I’m a gynecologic oncologist and a professor at the University of Arizona and the Creighton University School of Medicine in Phoenix, Arizona. I’m also a member of Arizona Oncology, part of the US Oncology Network, and the chair of the gynecologic oncology research unit within the US Oncology Network. I’m here today to tell you about an upcoming OncLive Peer Exchange®. This particular Peer Exchange® will review data from the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer and will focus on the exchange between investigators, providers, and members of the Society of Gynecologic Oncology and how this impacts the paradigm of treating advanced ovarian cancer.

Tune in to hear the latest and greatest news on targeted and immunologic agents, as well as sage advice on the sequencing and management of these novel approaches. You won’t want to miss this direct line of access to the approaches field-leading physicians are using to improve outcomes for their patients with ovarian cancer. In light of the insight we will glean from the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer, there is no better time to refine your knowledge and sink your teeth into practice-changing data that are forever moving us toward that proverbial cure. Once again, I’m Bradley Monk, and I hope you’ll join us for this cutting-edge OncLive Peer Exchange® program. I’ll see you there.

Transcript Edited for Clarity

SELECTED
LANGUAGE
Slider Left
Slider Right


Transcript: 

Bradley J. Monk, MD, FACOG, FACS: There has been great progress in improving outcomes for patients with ovarian cancer, but this remains an area of great challenge and heterogeneity. Much work remains before we can offer all patients a significant chance at cure. Emerging approaches to personalized treatment are continually moving us toward that goal, and the hope is that with a greater understanding of underlying biology and personalized care, we can continue to develop agents that are both efficacious and tolerable.

Greetings, my name is Bradley Monk. I’m a gynecologic oncologist and a professor at the University of Arizona and the Creighton University School of Medicine in Phoenix, Arizona. I’m also a member of Arizona Oncology, part of the US Oncology Network, and the chair of the gynecologic oncology research unit within the US Oncology Network. I’m here today to tell you about an upcoming OncLive Peer Exchange®. This particular Peer Exchange® will review data from the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer and will focus on the exchange between investigators, providers, and members of the Society of Gynecologic Oncology and how this impacts the paradigm of treating advanced ovarian cancer.

Tune in to hear the latest and greatest news on targeted and immunologic agents, as well as sage advice on the sequencing and management of these novel approaches. You won’t want to miss this direct line of access to the approaches field-leading physicians are using to improve outcomes for their patients with ovarian cancer. In light of the insight we will glean from the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer, there is no better time to refine your knowledge and sink your teeth into practice-changing data that are forever moving us toward that proverbial cure. Once again, I’m Bradley Monk, and I hope you’ll join us for this cutting-edge OncLive Peer Exchange® program. I’ll see you there.

Transcript Edited for Clarity
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x